141516-24-7

Basic information

• Product Name: 1-Piperazinepropanamine,4-acetyl-(9CI)
• Synonyms: 1-Piperazinepropanamine,4-acetyl-(9CI);3-(4-Acetylpiperazinyl)propanamine;1-(4-(3-Aminopropyl)piperazin-1-yl)ethanone;4-Acetyl-1-piperazinepropanamine;1-[4-(3-aminopropyl)-1-piperazinyl]Ethanone
• CAS NO: 141516-24-7
• Molecular Formula: C₉H₁₉N₃O
• Molecular Weight: 185.27
• Product Categories: PIPERIDINE
• Mol File: 141516-24-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 335.2 °C at 760 mmHg
• Flash Point: 156.5 °C
• Appearance: /
• Density: 1.043±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0.000122mmHg at 25°C
• Refractive Index: 1.5
• PKA: 10.39±0.10(Predicted)
• CAS DataBase Reference: 1-Piperazinepropanamine,4-acetyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperazinepropanamine,4-acetyl-(9CI)(141516-24-7)
• EPA Substance Registry System: 1-Piperazinepropanamine,4-acetyl-(9CI)(141516-24-7)

Safety Data

• Hazardous Substances Data: 141516-24-7(Hazardous Substances Data)

Usage

General Description

1-Piperazinepropanamine, 4-acetyl-(9CI) is a chemical compound that belongs to the class of organic compounds known as piperazines. Piperazines are compounds containing a piperazine ring, which is a saturated aliphosphate. This specific chemical, 1-Piperazinepropanamine, 4-acetyl-(9CI), includes an additional acetyl group, which significantly influences the chemical's properties and potential uses. It is important to note that this compound, like many other chemicals, must be handled appropriately due to its potential hazards and reactions. Further detailed information about this chemical regarding its specific characteristics, common applications, and related safety measures must be obtained from specific scientific resources or chemical databases.

InChI:InChI=1/C9H19N3O/c1-9(13)12-7-5-11(6-8-12)4-2-3-10/h2-8,10H2,1H3

Upstream product

• 960243-33-8 3-[(4-acetyl)piperazinyl]propanenitrile 

Relevant articles and documents

TRITERPENE AMINE DERIVATIVES

The present invention concerns novel pharmaceutically active triterpene amine derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the triterpene amine compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C-28 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus-1 (HIV-1).

2-Anilino-4-(Heterocyclic) Amino-Pyrimidines

The present invention relates to 2-arylamino-4-(heterocyclic)aminopyrimidines inhibitors which are inhibitors and therefore inhibit Protein Kinase C-alpha (PKC-α). The PKC-α inhibitors of the present invention are important for improving myocardial intracellular calcium cycling, resulting in improved myocardial contraction and relaxation performance and thereby slowing the progression of heart failure. The present invention further relates to compositions comprising said 2-arylamino-4-(heterocyclic)amino-pyrimidines and to methods for controlling, abating, or otherwise slowing the progression of heart failure.